AHCOHIGH SIGNALFINANCIAL10-K

AdaptHealth experienced a substantial decline in operating income while expanding operations and reducing debt levels.

The dramatic deterioration in operating profitability despite growing patient volumes and locations suggests significant margin compression or one-time charges that warrant investor scrutiny. The company appears to be investing in growth while managing leverage, but the profitability decline raises questions about operational efficiency or potential restructuring costs.

Comparing 2026-02-24 vs 2025-02-25View on EDGAR →
FINANCIAL ANALYSIS

AdaptHealth's financial profile shows mixed signals with operating income declining substantially while operating cash flow grew modestly to $601.8M. The company reduced total debt by 12.4% to $1.7B and increased capital expenditures by 25% to $382.4M, suggesting active investment in growth initiatives. However, current liabilities rose 26% to $712.4M, which combined with the operating income decline, indicates potential working capital or operational challenges that offset the positive cash generation and deleveraging efforts.

FINANCIAL STATEMENT CHANGES
Operating Income
P&L
-65.5%
$263.7M→$90.9M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Current Liabilities
Balance Sheet
+25.6%
$567.0M→$712.4M

Current liabilities rose 25.6% — increased short-term obligations, watch current ratio.

Capital Expenditure
Cash Flow
+24.9%
$306.1M→$382.4M

Capex increased 24.9% — ongoing investment in capacity or infrastructure for future growth.

Total Debt
Balance Sheet
-12.4%
$2.0B→$1.7B

Debt reduced 12.4% — deleveraging strengthens balance sheet and reduces financial risk.

Operating Cash Flow
Cash Flow
+11.1%
$541.8M→$601.8M

Operating cash flow grew 11.1% — strong conversion of earnings to cash, healthy business fundamentals.

LANGUAGE CHANGES
NEW — 2026-02-24
PRIOR — 2025-02-25
ADDED
As of February 20, 2026, there were 135,914,816 shares of the Registrant s Common Stock outstanding.
Securities and Exchange Commission not later than April 30, 2026.
2 SUMMARY RISK FACTORS AdaptHealth s business is subject to numerous risks and uncertainties, including those described in Item 1A, Risk Factors.
Sleep Health The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.
As of December 31, 2025, AdaptHealth serviced approximately 4.3 million patients annually in all 50 states through our network of approximately 640 locations in 48 states.
+7 more — sign up free →
REMOVED
As of February 21, 2025, there were 134,867,011 shares of the Registrant s Common Stock outstanding.
Securities and Exchange Commission not later than April 30, 2025.
Sleep Health The Sleep Health segment provides sleep therapy equipment, supplies and related services (including CPAP and BiLevel services) to individuals for the treatment of obstructive sleep apnea.
As of December 31, 2024, AdaptHealth serviced approximately 4.2 million patients annually in all 50 states through our network of approximately 660 locations in 47 states.
The Company's principal executive offices are located at 220 West Germantown Pike, Suite 250, Plymouth Meeting, Pennsylvania 19462.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →